ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 86 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $71,572 | +17.4% | 3,493 | +13.9% | 0.00% | +33.3% |
Q2 2023 | $60,961 | +22.7% | 3,068 | +5.8% | 0.00% | 0.0% |
Q1 2023 | $49,677 | -20.8% | 2,900 | -9.5% | 0.00% | 0.0% |
Q4 2022 | $62,722 | +52.1% | 3,205 | +24.0% | 0.00% | +50.0% |
Q3 2022 | $41,241 | +16.0% | 2,584 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $35,556 | -13.2% | 2,584 | 0.0% | 0.00% | +100.0% |
Q1 2022 | $40,982 | -82.8% | 2,584 | -76.3% | 0.00% | -66.7% |
Q4 2021 | $237,620 | -27.0% | 10,885 | 0.0% | 0.00% | -40.0% |
Q3 2021 | $325,353 | -32.5% | 10,885 | 0.0% | 0.01% | -28.6% |
Q2 2021 | $482,097 | +6.2% | 10,885 | +6.4% | 0.01% | 0.0% |
Q1 2021 | $453,994 | -22.0% | 10,232 | -3.6% | 0.01% | -22.2% |
Q4 2020 | $582,181 | +139.9% | 10,616 | 0.0% | 0.01% | +125.0% |
Q3 2020 | $242,682 | +9.2% | 10,616 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $222,193 | +50.0% | 10,616 | 0.0% | 0.00% | +33.3% |
Q1 2020 | $148,093 | -38.7% | 10,616 | 0.0% | 0.00% | -25.0% |
Q4 2019 | $241,620 | +95.4% | 10,616 | 0.0% | 0.00% | +100.0% |
Q3 2019 | $123,676 | +1.8% | 10,616 | +31.1% | 0.00% | 0.0% |
Q2 2019 | $121,455 | -6.5% | 8,097 | +9.4% | 0.00% | 0.0% |
Q1 2019 | $129,849 | +18.4% | 7,403 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $109,712 | -39.8% | 7,403 | 0.0% | 0.00% | -33.3% |
Q3 2018 | $182,262 | – | 7,403 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |